Wake-Promoting Actions of Dopamine D1 and D2 Receptor Stimulation
@article{Isaac2003WakePromotingAO,
title={Wake-Promoting Actions of Dopamine D1 and D2 Receptor Stimulation},
author={Stuart O Isaac and Craig W. Berridge},
journal={Journal of Pharmacology and Experimental Therapeutics},
year={2003},
volume={307},
pages={386 - 394}
}Multiple ascending neurotransmitter systems participate in the regulation of behavioral state. For example, noradrenergic, cholinergic, and serotonergic systems increase EEG and, in some cases, behavioral indices of arousal. The extent to which dopaminergic systems exert a similar activating influence on behavioral state remains unclear. The current studies examined the wake-promoting actions of centrally administered D1 and D2 receptor agonists. In these studies, intracerebroventricular…
110 Citations
Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat
- Biology, PsychologyProgress in Neuro-Psychopharmacology and Biological Psychiatry
- 2006
What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
- Biology, PsychologySleep
- 2004
Understanding the exact role of the hypocretin/orexin and dopamine systems in the physiology and pharmacology of sleep-wake regulation may reveal new insights into current and future wakefulness-promoting drugs.
The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.
- BiologySleep
- 2009
In rat synaptosomes, nomifensine reduced the potency of amphetamine to induce DA release approximately 270-fold, potentially explaining its action in ameliorating amphetamine-induced RHS.
Neural Substrates of Psychostimulant-Induced Arousal
- Psychology, BiologyNeuropsychopharmacology
- 2006
It is clear that both norepinephrine and dopamine contribute to psychostimulant-induced arousal, but the degree to which each transmitter system is necessary for the expression of stimulant- induced arousal remains to be fully elucidated.
Selective serotonin 2A receptor antagonism attenuates the effects of amphetamine on arousal and dopamine overflow in non‐human primates
- Biology, PsychologyJournal of sleep research
- 2013
It is found that amphetamine significantly and dose‐dependently increased arousal at doses that engendered higher extracellular dopamine levels, and it is suggested that increased dopamine neurotransmission may be necessary for the wake‐promoting effects of amphetamine, and possibly other stimulants.
Essential Role of Dopamine D2 Receptor in the Maintenance of Wakefulness, But Not in Homeostatic Regulation of Sleep, in Mice
- Biology, PsychologyThe Journal of Neuroscience
- 2010
The results indicate that D2R plays an essential role in the maintenance of wakefulness, but not in homeostatic regulation of NREM sleep.
Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.
- Psychology, BiologySleep
- 2010
A role for the dopamine system in regulating sleep attacks and cataplexy in a murine model of narcolepsy is shown and it is found that catapLexy is modulated by a D2-like receptor mechanism, whereas dopamine modulates sleep attacks by aD1-like receptors mechanism.
Hypocretin/Orexin Selectively Increases Dopamine Efflux within the Prefrontal Cortex: Involvement of the Ventral Tegmental Area
- Biology, PsychologyNeuropsychopharmacology
- 2006
The current observations predict a prominent modulatory influence of HCRT on PFC-dependent cognitive and affective processes that results, in part, from actions within the VTA.
Antagonism of D1, but not D2, dopamine receptors inhibits cued sucrose seeking by decreasing arousal
- Psychology, Biology
- 2021
The arousal-motor hypothesis is proposed, a novel synthesis that accounts both for the findings and many previous results that have drawn disparate and conflicting conclusions on dopamine’s contributions to behavior.
The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
- BiologyProgress in brain research
- 2008
References
SHOWING 1-10 OF 45 REFERENCES
Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat.
- Biology, PsychologyEuropean journal of pharmacology
- 1989
The dopamine D1 receptor is involved in the regulation of REM sleep in the rat.
- Biology, PsychologyEuropean journal of pharmacology
- 1991
Additive wake-promoting actions of medial basal forebrain noradrenergic α1- and β-receptor stimulation.
- Biology, Psychology
- 2003
Results show that alpha1-receptors located within MS exert wake-promoting actions, which contribute to the overall arousal state of the animal.
Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat.
- Biology, PsychologyThe Journal of pharmacology and experimental therapeutics
- 1993
Concomitant enhancement of both total sleep and REM appears to be a peculiar feature which clearly distinguishes DA D-1 antagonists from the other DA receptor blockers.
Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation.
- Biology, PsychologyBehavioral neuroscience
- 2003
Results show that alpha1-receptors located within MS exert wake-promoting actions, which contribute to the overall arousal state of the animal.
Synergistic sedative effects of noradrenergic α1- and β-receptor blockade on forebrain electroencephalographic and behavioral indices
- Biology, PsychologyNeuroscience
- 2000
Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices.
- Biology, PsychologyNeuroscience
- 2000
The results indicate that the combined actions of alpha(1)- and beta-receptors exert distinct and synergistic actions on cortical neuronal activity patterns that are essential elements of alert waking.
Effects of a D2 receptor agonist RO 41–9067 alone and with clonidine on sleep parameters in the rat
- Biology, PsychologyPharmacology Biochemistry and Behavior
- 1996
Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats
- Biology, MedicineEuropean Neuropsychopharmacology
- 1998
Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
- Biology, ChemistryNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- 1990
Neither SKF 38393 nor SCH 23390 exerted activity on the sleep-wake cycle, which could be considered to reflect effects at DA autoreceptors, however, a blockade of 5-HT2 receptors could be partly involved in these effects.




